Job Description
In Vitro Scientist (Receptor Pharmacology)\n\nLocation – Nottingham\n\nSector – Drug Discovery\n\nSalary – £32,000 - £40,000 (depending on interview performance & experience)\n\nFull Time, Permanent Role\n\nAre you experienced in receptor pharmacology with hands-on expertise in designing and running biochemical and cellular assays? We have an exciting opportunity to join a drug discovery company in Nottingham, supporting diverse client projects in cutting-edge drug discovery programs.\n\nApplicants must have current UK work eligibility.\n\nThe Role\n\nAs a Scientist within the receptor pharmacology team, you will be responsible for:\n\n * Design and perform in vitro biochemical and cell-based assays,\n\n * Provide high-quality data to support drug discovery projects,\n\n * Manage experiments and help train junior team members,\n\n * Work closely with clients and the team to solve complex research problems,\n\n * Contribute to research publications and present findings at scientific meetings.\n\nCurrent / Recent Experience Required:\n\nThe ideal candidate will have the following:\n\n * PhD or BSc / MSc with at least 4 years of professional experience in receptor pharmacology (essential).\n\n * Hands-on experience with in vitro molecular biology techniques – such as mammalian cell culture, western blotting, and flow cytometry (essential).\n\n * Experience working with dose-response curves and calculating EC50 / IC50 values (essential).\n\n * Expertise in pharmacology laboratory techniques, including binding assays, SPR assays, radioligand binding, reporter gene assays, luciferase reporter assay, β-galactosidase reporter assay (desirable).\n\n * Expertise in GPCR binding (desirable).\n\nProfile Required:\n\n * Existing UK work eligibility (essential).\n\n * Happy to commute / relocate to Nottingham (essential).\n\nThe Package\n\nOur client, a leading collaborative drug discovery company, offers a competitive salary and benefits package. This full-time role provides the opportunity to join a growing organization at the forefront of receptor pharmacology